Amfetamine

N/A

Report date: 2023/08/02 11:13:35

Base Information

Drug NameAmfetamine
Drug Alias NameAmphetamine orally disintegrating tablet - Neos Therapeutics安非他命Amfetamine controlled release (orally disintegrating tablet)Amphetamine extended-release - Neos TherapeuticsAmfetamine XR-ODT - Neos Therapeutics +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTrace amine-associated receptor 1 agonistsAdrenergic receptors agonists
TargetsTrace amine-associated receptor 1Adrenergic receptors
Therapy Area/IndicationsAutism Spectrum DisorderAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsAttention Deficit Disorder with Hyperactivity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2016/01/27
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNeos Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesNeos Therapeutics Inc
Inactive CompaniesDuke University
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsAutism Spectrum Disorder

Other Information

ATC CodeN06BA01
Related LinksN/A